Market Research Reports and Industry Reports

Infectious Disease Molecular Diagnostics : Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

This new seven-country study from VPGMarketResearch contains 775 pages, 73 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.

Report Highlights

- Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry.  The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.  The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.  Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

- France - Germany - Italy - Japan - Spain - UK - USA

Worldwide Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment.

- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components.

- Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.

- A comprehensive analysis of the sequencing market by country and laboratory segment.

- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country.

Product/Technology Review

- Comparison of leading infectious disease molecular diagnostic analyzers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.

- Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

   - Abbott    - Affymetrix    - Agilent Technologies    - Applied Gene Technologies    - Arca Biopharma    - Beckman Coulter/Danaher    - Becton Dickinson    - Biokit    - BioMerieux    - Bio-Rad    - Biotest    - CellMark Forensics/LabCorp    - Cepheid    - DecodeGenetics    - Diadexus    - Eiken    - Elitech Group    - Enzo    - Exact Sciences    - Fujirebio    - Grifols    - Hologic/Gen-Probe    - Illumina    - Kreatech/Leica    - Li-Cor Biosciences    - Monogram Biosciences    - Myriad Genetics    - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper Life Sciences    - Proteome Sciences    - Qiagen    - Roche    - Scienion    - Sequenom    - Shimadzu    - Siemens    - Sierra Molecular    - Takara Bio    - Tecan Group    - Thermo Fisher

- Comprehensive listings of companies developing and marketing infectious disease molecular diagnostic products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

I.Introduction
 
 II.Major Product Development Opportunities
 

 A. Instrumentation
 B. Reagent Kits and Test Systems/panels
 C. Computers, Software and Automation
 D. Auxiliary Products
 
 III.Design Criteria for Decentralized Testing Products
 
 IV.Alternative Market Penetration Strategies
 

 A. Internal Development
 B. Collaborative Arrangements
 C. University Contracts
 D. Distribution Strategies For Decentralized Testing
 Markets
 
 V.Potential Market Entry Barriers and Risks
 

 A. Market Maturity
 B. Cost Containment
 C. Competition
 D. Technological Edge And Limitations
 E. Patent Protection
 F. Regulatory Constraints
 G. Decentralized Testing Market Challenges
 
 VI. Worldwide Market and Technology Review
 
 A. DNA Sequencing
 
 1. Introduction
 2. Sequencing Methods
 3. Autoradiography
 4. The Human Genome Project
 5. Sequencing Automation
 Table of Contents
 (continued)
 6. Image Scanners
 7. Fluorescent Detection
 8. Gene Profiling
 9. Gene Expression
 10. Polymorphism Screening
 11. Protein Interaction Networks
 
 B. DNA and RNA Probe Technologies
 
 1. Basic Principles
 2. Probe Preparation
 3. The DNA Probe Test
 4. Test Formats
 5. Labeling Techniques
 6. Amplification Methods
 
 C. Detection Technologies
 
 1. Radioactive Methods
 a. Overview
 b. Major Isotopes
 O
 P-32
 O
 S-35
 O
 H-3
 O
 I-125
 2. Non-Isotopic Methods
 a. Enzymatic Labels
 b. Chemical Labeling
 O
 Indirect Chemical Labeling
 O
 Direct Chemical Labeling
 c. Fluorescence
 d. Chemiluminescence
 e. Electrical Conductivity
 
 D. Molecular Diagnostic Instrumentation Review
 
 1. Abbott LCx
 2. Beckman Coulter/Biomek FK
 3. BD Viper System with XTR Technology
 4. BD Innova
 5. Becton Dickinson SDA
 6. bioMerieux NucliSENS easyMAG
 7. bioMerieux NucliSENS easyQ and MiniMAG
 8. Bio-Rad GeneScope
 9. Cepheid GeneXpert
 10. Curetis Unyvero
 11. GenMark Dx eSensor XT-8
 12. Hologic/Gen-Probe Panther
 13. Hologic/Gen-Probe Tigris/DTS
 14. HTG Molecular Edge
 15. Life Technologies QuantStudio Dx
 16. Qiagen QIAsymphony RGQ
 17. Roche Cobas Amplicor
 18. Roche Cobas TaqMan 48
 19. Roche Cobas TaqMan
 20. Roche Cobas TaqMan AmpliPrep
 21. Roche LighCycler 480
 22. Roche Cobas 4800
 23. Roche Cobas s 201
 24. Siemens Versant
 25. Tecan LS Series
 E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
 - Liquid Transportation and Mixing
 - Separation
 - Reaction
 - Detection
 F. Pharmacogenomics
 G. Major Applications, Microbiology/Infectious Diseases
 a. Overview
 b. Major Infectious Diseases
 ° AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT,
    Western Blot, HTLV-I/II
 ° Adenovirus
 ° Aeromonas
 ° Anthrax/Bacillus Anthracis
 ° Arboviruses
 ° Babesiosis
 ° Bacillary Epithelioid Angiomatosis (BEA)
    and Other Bartonella (Rochalimaea)
 ° Blastocystis Hominis
 ° Brucella
 ° Campylobacter
 ° Candida
 ° Chagas Disease
 ° Chancroid
 ° Chlamydia
 ° Clostridium Difficile
 ° Coronaviruses
 ° Coxsackieviruses
 ° Creutzfeldt-Jakob’s Disease
 ° Cryptosporidium Parvum
 ° Cyclospora Cayetanensis
 ° Cytomegalovirus
 ° Ebola Virus
 ° E. Coli
 ° EchoVirus
 ° Encephalitis
 ° Enteroviruses
 ° Epstein-Barr Virus
 ° Giardia Lamblia
 ° Gonorrhea
 ° Granuloma Inguinale
 ° Hantavirus
 ° Helicobacter Pylori
 ° Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT,
   Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
   HBe Ag, ALT/SGPT
 ° Herpes Simplex Virus
 ° Human Herpes Virus-6 (HHV-6)
 ° Influenza Viruses
 ° Legionella
 ° Lyme Disease
 ° Lymphogranuloma Venereum (LGV)
 ° Malaria
 ° Measles (Rubeola)
 ° Meningitis
 Table of Contents
 (continued)
 ° Microsporidium
 ° Mononucleosis
 ° Mumps
 ° Mycoplasma
 ° Papillomaviruses
 ° Parvovirus B19
 ° Pneumonia
 ° Polyomaviruses
 ° Pseudomonas Aeruginosa
 ° Rabies
 ° Respiratory Syncytial Virus (RSV)
 ° Rhinoviruses
 ° Rotavirus
 ° Rubella
 ° Salmonellosis
 ° Septicemia
 ° Shigellosis
 ° Staphylococcus Aureus
 ° Streptococci
 ° Syphilis
 ° Toxoplasmosis
 ° Trichomonas Vaginalis
 ° Tuberculosis
 ° Vibrio
 ° West Nile Virus
 ° Yersina
 
 H. Competing/complementing
 
 1. Monoclonal Antibodies/Immunoassays
 2. RNA Probes
 3. Two-Dimensional Electrophoresis
 4. Flow Cytometry
 
 VII.Worldwide Market Overview
 1. Business Environment
 2. Market Structure
 3. Market Size and Growth
 
 VIII.France Molecular Diagnostics Market
 

 A. Executive Summary
 B. Business Environment
 C. Market Structure
 D. Market Size, Test Volume and Sales Forecasts,
 Major Supplier Sales and Market Shares
 
 IX. Germany Molecular Diagnostics Market
 

 A. Executive Summary
 B. Business Environment
 C. Market Structure
 D. Market Size, Test Volume and Sales Forecasts,
 Major Supplier Sales and Market Shares
 
 X.Italy Molecular Diagnostics Market
 

 A. Executive Summary
 B. Business Environment
 C. Market Structure
 D. Market Size, Test Volume and Sales Forecasts,
 Major Supplier Sales and Market Shares
 
 XI.Japan Molecular Diagnostics Market
 

 A. Executive Summary
 B. Business Environment
 C. Market Structure
 D. Market Size, Test Volume and Sales Forecasts,
 Major Supplier Sales and Market Shares
 
 XII. Spain Molecular Diagnostics Market
 

 A. Executive Summary
 B. Business Environment
 C. Market Structure
 D. Market Size, Test Volume and Sales Forecasts,
 Major Supplier Sales and Market Shares
 
 XIII.U.K. Molecular Diagnostics Market
 

 A. Executive Summary
 B. Business Environment
 C. Market Structure
 D. Market Size, Test Volume and Sales Forecasts,
 Major Supplier Sales and Market Shares
 
 XIV.U.S.A.
 Molecular Diagnostics Market
 A. Executive Summary
 B. Business Environment
 C. Market Structure
 D. Market Size, Test Volume and Sales Forecasts,
 Major Supplier Sales and Market Shares
 
 XV.Competitive Assessments
 

 - Abbott
 - Affymetrix
 - Agilent Technologies
 - Applied Gene Technologies
 - Arca Biopharma
 - Beckman Coulter/Danaher
 - Becton Dickinson
 - Biokit
 - bioMerieux
 - Bio-Rad
 - Biotest
 - Cepheid
 - CellMark Foren
 s
 ics/LabCorp
 - Decode Genetics
 - Diadexus
 - Eiken
 - Elitech Group
 - Enzo
 - Exact Sciences
 - Fujirebio
 - Grifols
 - Hologic
 /
 Gen-Probe
 Table of Contents
 (continued)
 - Illumina
 - Kreatech
 /Leica
 - Li-Cor Biosciences
 - Monogram Biosciences/LabCorp
 - Myriad Genetics
 - Ortho-Clinical Diagnostics
 - Perkin Elmer/Caliper
 - Proteome Sciences
 - Qiagen
 - Roche
 - Scienion
 - Sequenom
 - Shimadzu
 - Siemens
 - Sierra Molecular
 - Takara Bio
 - Tecan Group
 - Thermo Fisher
 
 XVI. Appendix:
 
  Major Universities and Research Centers
 Developing Molecular Diagnostic Technologies


List Of Tables

Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct
Identification Tests
Worldwide, Laboratories Performing DNA Sequencing
by Country
Worldwide, Molecular Diagnostics Market Potential
Laboratory Universe by Country
Worldwide, Molecular Diagnostic Test Volume Forecast
by Country
Worldwide, Molecular Diagnostics Market
Forecast by Country
France
Molecular Diagnostics Test Volume And Sales
By Major Application 2014-2019
France
Laboratories Performing DNA Sequencing
By Market Segment 2014
France
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment 2014
France
Molecular Diagnostics Test Volume
By Major Application 2014-2019
France
Major Infectious Disease Test Volume by Assay 2014-2019
France
Major Infectious Disease Test Volume by Method 2014
France
Molecular Diagnostics Market
By Major Application 2014-2019
France
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers 2014
France
Major Infectious Disease Diagnostics Market by Assay 2014-2019
France
AIDS Testing Market
Estimated Sales by Major Supplier 2014
France
Adenovirus Testing Market
Estimated Sales by Major Supplier 2014
France
Chlamydia Testing Market
Estimated Sales by Major Supplier 2014
France
CMV Testing Market
Estimated Sales by Major Supplier 2014
France
Gonorrhea Testing Market
Estimated Sales by Major Supplier 2014
France
Hepatitis Testing Market
Estimated Sales by Major Supplier 2014
France
Hepatitis C Testing Market
Estimated Sales by Major Supplier 2014
France
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier 2014
France
Herpes Testing Market
Estimated Sales by Major Supplier 2014
France
Influenza Testing Market
Estimated Sales by Major Supplier 2014
France
Meningitis Testing Market
Estimated Sales by Major Supplier 2014
France
Mycoplasma Testing Market
Estimated Sales by Major Supplier 2014
France
RSV Testing Market
Estimated Sales by Major Supplier 2014
France
Shigella Testing Market
Estimated Sales by Major Supplier 2014
Germany
Molecular Diagnostics Test Volume And Sales
By Major Application 2014-2019
Germany
Laboratories Performing DNA Sequencing
By Market Segment 2014
Germany
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment 2014
Germany
Molecular Diagnostics Test Volume
By Major Application 2014-2019
Germany
Major Infectious Disease Test Volume by Assay 2014-2019
Germany
Major Infectious Disease Test Volume by Method 2014
Germany
Molecular Diagnostics Market
By Major Application 2014-2019
Germany
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers 2014
Germany
Major Infectious Disease Diagnostics Market by Assay 2014-2019
Germany
AIDS Testing Market
Estimated Sales by Major Supplier 2014
Germany
CMV Testing Market
Estimated Sales by Major Supplier 2014
Germany
EBV Testing Market
Estimated Sales by Major Supplier 2014
Germany
Gonorrhea Testing Market
Estimated Sales by Major Supplier 2014
Germany
Hepatitis Testing Market
Estimated Sales by Major Supplier 2014
Germany
Hepatitis C Testing Market
Estimated Sales by Major Supplier 2014
Germany
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier 2014
Germany
Herpes Testing Market
Estimated Sales by Major Supplier 2014
Germany
Influenza Testing Market
Estimated Sales by Major Supplier 2014
Germany
Meningitis Testing Market
Estimated Sales by Major Supplier 2014
Germany
Mycoplasma Testing Market
Estimated Sales by Major Supplier 2014
Germany
Pneumonia Testing Market
Estimated Sales by Major Supplier 2014
Germany
RSV Testing Market
Estimated Sales by Major Supplier 2014
Germany
Rotavirus Testing Market
Estimated Sales by Major Supplier 2014
Italy
Molecular Diagnostics Test Volume And Sales
By Major Application 2014-2019
Italy
Laboratories Performing DNA Sequencing
By Market Segment 2014
Italy
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment 2014
Italy
Molecular Diagnostics Test Volume
By Major Application 2014-2019
Italy
Major Infectious Disease Test Volume by Assay 2014-2019
Italy
Major Infectious Disease Test Volume by Method 2014
Italy
Molecular Diagnostics Market
By Major Application 2014-2019
Italy
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers 2014
Italy
Major Infectious Disease Diagnostics Market by Assay 2014-2019
Italy
AIDS Testing Market
Estimated Sales by Major Supplier 2014
Italy
CMV Testing Market
Estimated Sales by Major Supplier 2014
Italy
Gonorrhea Testing Market
Estimated Sales by Major Supplier 2014
Italy
Hepatitis Testing Market
Estimated Sales by Major Supplier 2014
Italy
Hepatitis C Testing Market
Estimated Sales by Major Supplier 2014
Italy
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier 2014
Italy
Herpes Testing Market
Estimated Sales by Major Supplier 2014
Italy
Influenza Testing Market
Estimated Sales by Major Supplier 2014
Italy
Meningitis Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Echovirus Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Enterovirus Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
EBV Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Gonorrhea Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Hepatitis Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Hepatitis C Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier 2014
U.S.A.
Herpes Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Influenza Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Meningitis Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Mycoplasma Testing Market
Estimated Sales by Major Supplier 2014
List of Tables
(continued)
U.S.A.
Pneumonia Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Rabies Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
RSV Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Salmonella Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
Shigella Testing Market
Estimated Sales by Major Supplier 2014
U.S.A.
West Nile Virus Nat Market
Reagent Sales by Major Supplier 2014


Global Infectious Diagnostics Multiple Parameters Panel Market Research Report 2016

Notes:Production, means the output of Infectious Diagnostics Multiple Parameters PanelRevenue, means the sales value of Infectious Diagnostics Multiple Parameters PanelThis report studies Infectious Diagnostics Multiple Parameters Panel in Global market,

USD 2900View Report

China Infectious Disease Testing Instrumentation Industry 2015 Market Research Report

The China Infectious Disease Testing Instrumentation Industry 2015 Market Research Report is a professional and in-depth study on the current state of the infectious disease testing instrumentation industry.The report provides

USD 3200View Report

Infectious Disease Point of Care Testing - Current and Future Players

Infectious Disease Point of Care Testing - Current and Future PlayersThe infectious disease point of care testing (POCT) market is very fragmented, with over 100 players currently marketing products in

USD 3500View Report

China Infectious Disease Testing Instrumentation Industry 2015 Market Research Report

The China Infectious Disease Testing Instrumentation Industry 2015 Market Research Report is a professional and in-depth study on the current state of the infectious disease testing instrumentation industry.The report provides

USD 3200View Report

Infectious Disease Point of Care Testing - Current and Future Players

Infectious Disease Point of Care Testing - Current and Future PlayersThe infectious disease point of care testing (POCT) market is very fragmented, with over 100 players currently marketing products in

USD 3500View Report

Infectious Disease Point of Care Testing - APAC Analysis and Market Forecasts

Infectious Disease Point of Care Testing - APAC Analysis and Market ForecastsWith just under $700m in annual worldwide sales, the infectious disease point-of-care testing (POCT) market represents a major growth

USD 4450View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF $ 19500    $ 19500
  • Global Licence $ 42900    $ 42900
  • DataPack $ 12500    $ 12500
$ 19500

Reports Details

Published Date : Aug 2016
No. of Pages :775
Country :Global
Category :Healthcare
Publisher :VPGMarketResearch.com
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment